Skip to main content

Table 6 Table showing multiplicity and axillary lymph nodes status by the different imaging modalities in neo-adjuvant group

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Multiplicity Multiplicity Count %
SM post chemotherapy Single 7/13 53.8%
Multiple 3/13 23.1%
No 3/13 23.1%
DCE-MRI post chemotherapy Single 6/13 46.2%
Multiple 3/13 23.1%
No 4/13 30.8%
Postoperative pathology Single 3/13 23.1%
Multiple 3/13 23.1%
Lymph nodes LN status Count %
SM post chemotherapy ALN Pathological 5/13 30.8%
Non specific 8/13 61.5%
SM post chemotherapy other LNs Non specific 13/13 100.0%
DCE-MRI post chemotherapy ALN pathological 5/13 38.4%
Non specific 8/13 61.5%
MRI Post chemotherapy other LNs Non specific 13/13 100.0%
DWI-MRI post chemotherapy ALN pathological 4/13 30.8%
Non specific 9/13 69.2%
DWI-MRI post chemotherapy other LNs Non specific 13/13 100.0%
Postoperative pathology pathological 5/13 38.4%
Non specific 8/13 61.5%